1,533
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Oral depot antipsychotic drugs: time for a paradigm shift?

&

References

  • Cummings J. (1998). Microspheres as a drug delivery system in cancer therapy. Expert Opin Therapeut Patents, 8, 153–71
  • Gray R, Spilling R, Burgess D, Newey T. (2009). Antipsychotic long-acting injections in clinical practice: Medication management and patient choice. Br J Psychiat, 195, S51–6
  • Haddad PM, Taylor M, Niaz OS. (2006). First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: Systematic review of randomised controlled trials and observational studies. Br J Psychiat, 52, S20–8
  • Janssen PAJ. (1972). Long-acting neuroleptics and other psychoactive drugs on the future. Clin Med, 79, 12–14
  • Kirson NY, Weiden PJ, Yermakov S, et al. (2013). Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: Synthesizing results across different research designs. J Clin Psychiat, 74, 568–75
  • Kishimoto T, Robenzadeh A, Leucht C, et al. (2014). Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: A meta-analysis of randomized trials. Schizophr Bull, 40, 192–213
  • Leucht S, Tardy M, Komossa K, et al. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet, 379, 2063–71
  • NICE. (2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. Clin Guidelines, CG76
  • Novick D, Haro JM, Suarez D, et al. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiat Res, 176, 109–13
  • Pandey R, Khuller GK. (2004). Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. J Antimicrob Chemother, 53, 635–40
  • Soares BG, Lima MS. (2006). Penfluridol for schizophrenia. Cochrane Database Syst Rev, 19, CD002923
  • Valenstein M, Ganoczy D, McCarthy JF, et al. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. J Clin Psychiat, 67, 1542–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.